91 related articles for article (PubMed ID: 15785969)
1. Analysis of Epstein-Barr virus gene expression upon phorbol ester and hydroxyurea treatment by real-time quantitative PCR.
Pan YR; Fang CY; Chang YS; Chang HY
Arch Virol; 2005 Apr; 150(4):755-70. PubMed ID: 15785969
[TBL] [Abstract][Full Text] [Related]
2. Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis.
Li C; Chen RS; Hung SK; Lee YT; Yen CY; Lai YW; Teng RH; Huang JY; Tang YC; Tung CP; Wei TT; Shieh B; Liu ST
J Virol Methods; 2006 May; 133(2):158-66. PubMed ID: 16384612
[TBL] [Abstract][Full Text] [Related]
3. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
[TBL] [Abstract][Full Text] [Related]
5. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
7. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.
Ballout M; Germi R; Fafi-Kremer S; Guimet J; Barguès G; Seigneurin JM; Morand P
J Virol Methods; 2007 Jul; 143(1):38-44. PubMed ID: 17368820
[TBL] [Abstract][Full Text] [Related]
8. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
9. Multiprimed cDNA synthesis followed by PCR is the most suitable method for Epstein-Barr virus transcript analysis in small lymphoma biopsies.
Brink AA; Oudejans JJ; Jiwa M; Walboomers JM; Meijer CJ; van den Brule AJ
Mol Cell Probes; 1997 Feb; 11(1):39-47. PubMed ID: 9076713
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
11. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines.
Jiang R; Kanamori M; Satoh Y; Fukuda M; Ikuta K; Murakami M; Sairenji T
J Med Virol; 2003 Jun; 70(2):244-52. PubMed ID: 12696111
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.
Lu CC; Jeng YY; Tsai CH; Liu MY; Yeh SW; Hsu TY; Chen MR
Virology; 2006 Feb; 345(2):358-72. PubMed ID: 16298410
[TBL] [Abstract][Full Text] [Related]
13. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle.
Jiang JH; Wang N; Li A; Liao WT; Pan ZG; Mai SJ; Li DJ; Zeng MS; Wen JM; Zeng YX
J Clin Virol; 2006 Oct; 37(2):98-103. PubMed ID: 16931136
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression.
Feng WH; Kenney SC
Cancer Res; 2006 Sep; 66(17):8762-9. PubMed ID: 16951192
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
[TBL] [Abstract][Full Text] [Related]
17. Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein-Barr virus reactivation in a nasopharyngeal carcinoma cell line.
Lee CH; Fang CY; Sheu JJ; Chang Y; Takada K; Chen JY
Cancer Genet Cytogenet; 2008 Aug; 185(1):1-10. PubMed ID: 18656687
[TBL] [Abstract][Full Text] [Related]
18. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
19. Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression.
Bergallo M; Costa C; Baro S; Musso T; Balbo L; Merlino C; Cavallo R
J Biotechnol; 2007 Feb; 128(3):462-76. PubMed ID: 17147963
[TBL] [Abstract][Full Text] [Related]
20. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
